We are live on ! Find out more
SER icon

Serina Therapeutics
SER

35 hedge funds and large institutions have $5.28M invested in Serina Therapeutics in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

18% more capital invested

Capital invested by funds: $4.46M → $5.28M (+$823K)

13% more funds holding

Funds holding: 31 → 35 (+4)

0.01% more ownership

Funds ownership: 0.36% → 0.36% (+0.01%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
35
Holders Change
+4
Holders Change %
+12.9%
% of All Funds
0.54%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
6
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$25.6K
2
Jane Street
Jane Street
New York
+$21.6K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$20.4K
4
SWIG
Strategic Wealth Investment Group
Kentucky
+$14.8K
5
UBS Group
UBS Group
Switzerland
+$12K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$38K
2
Morgan Stanley
Morgan Stanley
New York
-$108
3
DC
Defender Capital
North Carolina
-$81
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Broadwood Capital
New York
$3.27M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$764K – – –
BlackRock
3
BlackRock
New York
$214K +$1.54K +57 +1%
PGP
4
Prescott General Partners
Florida
$202K – – –
BCM
5
Bridgeway Capital Management
Texas
$185K – – –
SWIG
6
Strategic Wealth Investment Group
Kentucky
$122K +$14.8K +549 +21%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$107K – – –
SPC
8
Sigma Planning Corp
Michigan
$96K – – –
DC
9
Defender Capital
North Carolina
$38K -$81 -3 -0.3%
VF
10
Virtu Financial
New York
$36K +$25.6K +947 New
Creative Planning
11
Creative Planning
Kansas
$35K +$378 +14 +2%
Northern Trust
12
Northern Trust
Illinois
$34K – – –
Jane Street
13
Jane Street
New York
$31K +$21.6K +799 New
State Street
14
State Street
Massachusetts
$29K – – –
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$29K +$20.4K +754 New
SXL
16
Summit X LLC
Missouri
$28K +$3.84K +142 +24%
BWCS
17
Beirne Wealth Consulting Services
Connecticut
$20K – – –
UBS Group
18
UBS Group
Switzerland
$17K +$12K +445 +22,250%
Millennium Management
19
Millennium Management
New York
$14K +$10.1K +373 New
Morgan Stanley
20
Morgan Stanley
New York
$3K -$108 -4 -4%
Osaic Holdings
21
Osaic Holdings
Arizona
$3K – – –
TRCT
22
Tower Research Capital (TRC)
New York
$2K – – –
CA
23
CoreCap Advisors
Michigan
$1K – – –
CC
24
Corsicana & Co
Texas
$1K – – –
PSB
25
Piscataqua Savings Bank
New Hampshire
$1K – – –
1
2

SER Hedge Fund Activity: Q4 2021 in Review

35 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q4 2021, worth a combined $5.28M — up 18% from $4.46M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new SER positions and 3 closed out — a net gain of 4 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $25.6K. The largest seller was Citadel Advisors, exiting entirely with an estimated $38K sold.

  • 35 institutional investors held Serina Therapeutics (SER) as of Q4 2021, up from 31 in Q3 2021.
  • Funds reported $5.28M of Serina Therapeutics stock for Q4 2021, up 18% quarter-over-quarter.
  • 7 funds opened new Serina Therapeutics positions in Q4 2021 and 3 closed out, a net change of +4 holders.
  • The largest Serina Therapeutics buyer in Q4 2021 was Virtu Financial, an estimated $25.6K added.
  • The largest Serina Therapeutics seller in Q4 2021 was Citadel Advisors, an estimated $38K sold.

Based on aggregated 13F filings for Q4 2021.